Form 8-K - Current report:
SEC Accession No. 0001493152-23-006504
Filing Date
2023-03-02
Accepted
2023-03-02 08:30:24
Documents
14
Period of Report
2023-03-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35635
2 ex99-1.htm EX-99.1 85388
3 ex99-1_002.jpg GRAPHIC 5776
  Complete submission text file 0001493152-23-006504.txt   314999

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE rnxt-20230302.xsd EX-101.SCH 3227
5 XBRL LABEL FILE rnxt-20230302_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE rnxt-20230302_pre.xml EX-101.PRE 22359
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3712
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

IRS No.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40738 | Film No.: 23696519
SIC: 2834 Pharmaceutical Preparations